GlobeMed Pharma Group is a Swiss-based pharmaceutical innovator delivering high-purity, plant-derived APIs at commercial scale. Produced under full EU GMP and Swiss GMP certification, our cannabinoids set a new benchmark for pharmaceutical precision, regulatory compliance, and natural origin integrity.
With a vertically integrated, tonnage-scale production platform, we supply pharmaceutical manufacturers, CDMOs, and research institutions worldwide, offering natural, scalable, and sustainable solutions that redefine what’s possible in cannabinoid medicine.